The Québec Cancer Consortium for Novel Therapeutics and Biomarkers (QCC), a collaboration between six leading hospital and cancer research centre sites based in Montreal led by McGill University’s Goodman Cancer Research Centre (GCRC) was awarded $10M in new funding from the Ministère de l’Économie et de l’Innovation (MEI) du Québec through its Fonds d’accélération des collaborations en santé (FACS) program.
Published on: 4 Jun 2019
Researchers find clue to rare genetic disorder
Leber hereditary optic neuropathy (LHON) is an inherited form of vision loss that causes people to have trouble with their colour vision and difficulty seeing in the centre of their visual field. Due to the founder effect from the filles du roi, there is a disproportionate preponderance of a particular LHON mutation among the French-Canadian population.
Published on: 22 May 2019
Study could lead to development of personalized biomarkers and treatment
Individuals with autism spectrum disorder (ASD) are often lumped into a single catch-all group, despite significant differences in symptom profile and severity. Further muddying the waters when trying to understand and treat ASD, many previous studies show significant variability in findings.
Published on: 8 May 2019
McGill University’s Faculty of Medicine unveiled a new strategic research plan (SRP) for the Faculty in 2014, which was subsequently updated in 2017 as part of the strategic planning exercise known as Project Renaissance. Dr. Shari Baum, who recently assumed the role of Vice-Dean, Life Sciences, played an important role in the development of the most recent version of the plan. Dr.
Published on: 26 Apr 2019
The telomerase holoenzyme responsible for maintaining telomeres in vertebrates requires many components in vivo, including dyskerin. Dyskerin binds and regulates the accumulation of the human telomerase RNA, hTR, as well as other non-coding RNAs that share the conserved H/ACA box motif. The precise mechanism by which dyskerin controls hTR levels is unknown, but is evidenced by defective hTR accumulation caused by substitutions in dyskerin, that are observed in the X-linked telomere biology disorder dyskeratosis congenita (X-DC).
Category:
Published on: 23 Apr 2019
Adrien Peyrache and Stuart Trenholm will study epilepsy and vision
Two researchers from The Neuro are among just ten nationwide to receive Early-Career Capacity Building Grants this year from the Azrieli Foundation in partnership with the Brain Canada Foundation. Researchers Adrien Peyrache and Stuart Trenholm will study epilepsy and vision, respectively. The grants support early-career investigators who are conducting transformative research to advance understanding of the brain, in illness or health.
Category:
Published on: 11 Mar 2019
Large international study will help select and categorize patients for better clinical trials
A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development.
Category:
Published on: 4 Mar 2019
Scientists prove difference between expected/actual outcomes cause reward response
If you love it when a musician strikes that unexpected but perfect chord, you are not alone. New research shows the musically unexpected activates the reward centre of our brains, and makes us learn about the music as we listen.
Category:
Published on: 12 Feb 2019
Researchers seek to answer longstanding debate
Published on: 11 Feb 2019
Scanner will deliver clear images of the nervous system in exceptional detail
Scientists will see the human nervous system in microscopic detail thanks to the installation of Canada’s first 7-Tesla whole-body magnetic resonance imaging (MRI) scanner on Feb. 5.
Category:
Published on: 5 Feb 2019
Technique involves use of non-invasive digital infrared imaging
Published on: 31 Jan 2019
Reinhardt lab receives 5-year CIHR grant to investigate extracellular matrix-mediated regulation of microRNAs in health and disease. Congratulations!
Category:
Published on: 24 Jan 2019
McGill and MUHC research teams part of an international effort to uncover how chronic inflammation causes cancer
Published on: 23 Jan 2019
Ghrelin promotes conditioning to food-related odours
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty food smells, encouraging overeating and obesity. New research on the hormone ghrelin was published on Dec. 4, 2018, led by Dr. Alain Dagher’s lab at the Montreal Neurological Institute and Hospital of McGill University.
Category:
Published on: 12 Dec 2018
Reducing stigma may address cognitive impairment in this population
A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.
Category:
Published on: 27 Nov 2018
Pages
